Approvals/TGA/SalplusF Inhaler 250/25 fluticasone propionate/salmeterol (as xinafoate) 250 microgram/25 microgram inhalation pressurised aerosol can metered dose

Approved

STANDARD

SalplusF Inhaler 250/25 fluticasone propionate/salmeterol (as xinafoate) 250 microgram/25 microgram inhalation pressurised aerosol can metered dose

Cipla Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Date: May 30, 2025
Approval ID: 0475a43bcbc258a4
Company: Cipla Australia Pty Ltd
Type: Standard

Approval Details

Approval Id: 0475a43bcbc258a4
Product Name: SalplusF Inhaler 250/25 fluticasone propionate/salmeterol (as xinafoate) 250 microgram/25 microgram inhalation pressurised aerosol can metered dose
Artg Id: 267105
Artg Name: SalplusF Inhaler 250/25 fluticasone propionate/salmeterol (as xinafoate) 250 microgram/25 microgram inhalation pressurised aerosol can metered dose
Sponsor: Cipla Australia Pty Ltd
Company Detail Path: /organization/cipla-australia-pty-ltd
Artg Date: 2016-12-15
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/ff6d4c13f8aedb5e8e49d8fbbac9070d.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/8656c3c1dc38dffbd05fcaa9819c67c9.pdf

Active Ingredients

Approved

Quick Info

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

0475a43bcbc258a4

Type

Standard

Back to TGA Approvals